CN1167805C - 用酶水解人参皂甙制备20-β-D-吡喃葡萄糖基原人参二醇 - Google Patents
用酶水解人参皂甙制备20-β-D-吡喃葡萄糖基原人参二醇 Download PDFInfo
- Publication number
- CN1167805C CN1167805C CNB01133410XA CN01133410A CN1167805C CN 1167805 C CN1167805 C CN 1167805C CN B01133410X A CNB01133410X A CN B01133410XA CN 01133410 A CN01133410 A CN 01133410A CN 1167805 C CN1167805 C CN 1167805C
- Authority
- CN
- China
- Prior art keywords
- hydrolysis
- protopanoxadiol
- ginsenoside
- prepare
- glucopyranosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229930182494 ginsenoside Natural products 0.000 title claims abstract description 23
- 229940089161 ginsenoside Drugs 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 21
- 230000003301 hydrolyzing effect Effects 0.000 title description 7
- 230000007062 hydrolysis Effects 0.000 claims abstract description 35
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 56
- 238000001556 precipitation Methods 0.000 claims description 27
- 230000003252 repetitive effect Effects 0.000 claims description 18
- 238000005201 scrubbing Methods 0.000 claims description 18
- 108060004795 Methyltransferase Proteins 0.000 claims description 16
- 150000002009 diols Chemical class 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 239000012452 mother liquor Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 239000006210 lotion Substances 0.000 claims description 9
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 9
- 229930182490 saponin Natural products 0.000 claims description 9
- 238000013016 damping Methods 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- 150000007949 saponins Chemical class 0.000 claims description 8
- FVIZARNDLVOMSU-IRFFNABBSA-N ginsenoside C-K Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FVIZARNDLVOMSU-IRFFNABBSA-N 0.000 claims description 4
- 239000000344 soap Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 4
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- 108010087005 glusulase Proteins 0.000 abstract 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract 1
- 125000003147 glycosyl group Chemical group 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 239000007979 citrate buffer Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 2
- -1 ginsenoside K compound Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- 150000008131 glucosides Chemical group 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- PQRHBEQNPCVBSM-UHFFFAOYSA-M potassium;2-carboxybenzoate;hydrochloride Chemical compound Cl.[K+].OC(=O)C1=CC=CC=C1C([O-])=O PQRHBEQNPCVBSM-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB01133410XA CN1167805C (zh) | 2001-11-06 | 2001-11-06 | 用酶水解人参皂甙制备20-β-D-吡喃葡萄糖基原人参二醇 |
PCT/CN2002/000786 WO2003040383A1 (fr) | 2001-11-06 | 2002-11-05 | Obtention de 20-$g(b)-d-pyranoglucosyl-protopanaxadiol par hydrolyse enzymatique du ginsenoside |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB01133410XA CN1167805C (zh) | 2001-11-06 | 2001-11-06 | 用酶水解人参皂甙制备20-β-D-吡喃葡萄糖基原人参二醇 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1417345A CN1417345A (zh) | 2003-05-14 |
CN1167805C true CN1167805C (zh) | 2004-09-22 |
Family
ID=4671790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB01133410XA Expired - Fee Related CN1167805C (zh) | 2001-11-06 | 2001-11-06 | 用酶水解人参皂甙制备20-β-D-吡喃葡萄糖基原人参二醇 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1167805C (zh) |
WO (1) | WO2003040383A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1508146A (zh) * | 2002-12-13 | 2004-06-30 | 中国科学院大连化学物理研究所 | 一种新型抗肿瘤人参皂苷 |
CN1305479C (zh) * | 2003-09-28 | 2007-03-21 | 中国科学院大连化学物理研究所 | 具有抗肿瘤活性的低极性人参皂苷组合物 |
US8541035B2 (en) | 2009-05-14 | 2013-09-24 | Il Hwa Co., Ltd. | Methods for preparing a fermented ginseng concentrate or powder |
WO2010134650A1 (en) * | 2009-05-19 | 2010-11-25 | Il Hwa Co., Ltd. | Methods for preparing a fermented ginseng concentrate or powder |
CN101768619A (zh) * | 2010-02-10 | 2010-07-07 | 华侨大学 | 一种以Rd为底物制备稀有人参皂甙IH-901的方法 |
CN102154417A (zh) * | 2010-12-13 | 2011-08-17 | 天津中医药大学 | 一种杠柳次苷的制备方法 |
CN102251009A (zh) * | 2011-06-09 | 2011-11-23 | 华侨大学 | 一种稀有人参皂甙ih-901结晶的简易生产方法 |
CN106008646A (zh) * | 2012-04-01 | 2016-10-12 | 浙江海正药业股份有限公司 | 人参皂苷c-k化合物多晶型及其制备方法 |
CN105949264A (zh) | 2012-04-01 | 2016-09-21 | 浙江海正药业股份有限公司 | 人参皂苷c-k的两种晶型及其制备方法 |
CN103073611B (zh) * | 2013-01-10 | 2015-10-28 | 天津大学 | 一种人参皂苷c-k半水合物晶体及制备方法 |
CN104622928A (zh) * | 2015-01-04 | 2015-05-20 | 中国药科大学 | 人参总皂苷通过激活IL-1β/IL-18活化分泌发挥免疫调节作用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0733335B2 (ja) * | 1991-06-21 | 1995-04-12 | 卓夫 小菅 | サポニン誘導体を含有する補気薬 |
KR0178863B1 (ko) * | 1996-11-29 | 1999-04-01 | 김진하 | 인삼 사포닌 대사 생산물의 제조법 |
CN1061986C (zh) * | 1998-01-22 | 2001-02-14 | 白求恩医科大学基础医学院 | 人参分组皂甙的制备方法,其药物组合物及应用 |
-
2001
- 2001-11-06 CN CNB01133410XA patent/CN1167805C/zh not_active Expired - Fee Related
-
2002
- 2002-11-05 WO PCT/CN2002/000786 patent/WO2003040383A1/zh not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003040383A1 (fr) | 2003-05-15 |
CN1417345A (zh) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1167805C (zh) | 用酶水解人参皂甙制备20-β-D-吡喃葡萄糖基原人参二醇 | |
JP3041539B2 (ja) | キシリトールおよびエタノールの同時生産方法 | |
CN101497904B (zh) | 一种同时生产木糖醇与阿拉伯糖的方法 | |
CN1715255A (zh) | 一种用虾壳生产甲壳素、虾青素、蛋白质、钙粉和生物肥料的方法 | |
CN112210548A (zh) | 一种表达α-L-鼠李糖苷酶的毕赤酵母及其制备方法和应用 | |
CN101991624A (zh) | 一种从积雪草中制备积雪草总酸、积雪草酸、羟基积雪草酸的方法及所得制备物的用途 | |
CN1384088A (zh) | 一种从虎杖植物中提取白藜芦醇的制备方法 | |
CN101701211B (zh) | 一种高效提取纯化油菜脂肪酶的方法 | |
CN86105166A (zh) | 生产人参皂甙-Rd的一种方法 | |
JPS6312300A (ja) | ジンセノサイド−Rdの製造法 | |
CN113337547A (zh) | 一种酒糟综合再利用的方法 | |
CN112961891A (zh) | 利用双相酶促反应制备淫羊藿苷的方法 | |
CN102002072A (zh) | 一种从枣核中提取黄酮的工艺方法 | |
CN1680571A (zh) | 麦芽三糖的制备方法 | |
CN101215587A (zh) | 无溶剂体系生物催化快速合成阿魏酸甘油酯的方法 | |
CN1173042C (zh) | 微生物酶法制备d-泛醇的方法 | |
CN113322287A (zh) | 一种通过植酸酶得到肌醇的方法 | |
KR100218553B1 (ko) | 진세노사이드 rg3의 제조방법 | |
CN1563400A (zh) | 一种分离制备灵菌红素的方法 | |
CN109824750A (zh) | 一种人参稀有皂苷的制备方法 | |
CN1557830A (zh) | 一种20(R)—人参皂苷Rh2的制备方法 | |
CN1268764C (zh) | 酶法水解薯蓣类皂甙糖基制备低糖基薯蓣皂甙的方法 | |
CN1491958A (zh) | 人参三醇型皂苷Re2结构修饰富集人参皂苷Rg2工艺 | |
CN1164743C (zh) | 从甘蔗的嫩叶中提取过氧化物酶的方法 | |
CN1660794A (zh) | D,l-苯丙氨酸酯或其盐手性拆分方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LUYE NATURAL MEDICINAL RESEARCH DEVELOPING CO., L Free format text: FORMER OWNER: DALIAN INST OF CHEMICOPHYSICS, CHINESE ACADEMY OF SCIENCES Effective date: 20080222 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080222 Address after: No. 9, Po Yuen Road, Laishan District, Yantai, Shandong Patentee after: Luye Natural Medicinal Research Developing Co., Ltd., Shandong Prov. Address before: No. 457, Zhongshan Road, Liaoning, Dalian Patentee before: Dalian Institute of Chemical Physics, Chinese Academy of Sciences |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170613 Address after: 264670, No. 15, pioneering Road, hi tech Zone, Shandong, Yantai Patentee after: Shandong Luye Pharma Co., Ltd. Address before: 264003 Laishan, Shandong Province Bao Road, No. 9 District, No. Patentee before: Luye Natural Medicinal Research Developing Co., Ltd., Shandong Prov. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040922 Termination date: 20181106 |